Table 2 Preintervention and postintervention diabetes process and patient outcome measures.
| Variable | Pre‐CRM mean percentage | Post‐CRM mean percentage | Post–pre per cent change | p Value | Interrupted time‐series effect p value |
|---|---|---|---|---|---|
| Diabetes process measure | |||||
| A1c within 3 months | 78.07 | 81.07 | +3.06 | 0.1144 | 0.03796 (0.029) |
| BP within 3 months | 97.35 | 97.87 | +0.52 | 0.4799 | 0.00529 (0.4933) |
| LDL within 12 months | 78.10 | 78.67 | +0.57 | 0.7751 | 0.00051 (0.9819) |
| MiAL within 12 months | 54.88 | 64.40 | +9.52 | <0.001 | 0.07403 (0.0002) |
| LEAP within 12 months | 50.14 | 59.07 | +8.93 | <0.001 | * |
| All services | 71.70 | 76.21 | +4.51 | <0.001 | * |
| Patient outcome measure | |||||
| A1c <7.0 | 31.94 | 28.67 | –3.28 | 0.1367 | –0.03811 (0.0110) |
| BP <130/80 | 39.94 | 42.27 | +2.55 | 0.2773 | 0.01704 (0.4887) |
| LDL <100 | 33.74 | 35.73 | +2.01 | 0.3815 | 0.00548 (0.7041) |
| MiAL <30 mg | 37.63 | 42.67 | +5.04 | 0.0312 | 0.03867 (0.0180) |
| LEAP score 0 | 49.67 | 55.07 | +5.40 | 0.0237 | * |
| All outcomes at or below target | 38.54 | 40.88 | +2.34 | 0.0460 | 0.024989 (0.0986) |
A1c, blood sugar level; BP, blood pressure; CRM, crew resource management; LDL, low‐density lipoprotein; LEAP, lower extremity amputation prevention; MiAL, microalbumin.
*A significant positive preintervention trend followed by a significant negative postintervention trend was found for these variables.